Biovica Q1 2022/23: FDA Approval - Redeye

Biovica is preparing ahead of the US launch, and the next milestone is to secure a certification for its own lab in San Diego servicing the US market. We expect the lab to be certified later in October or November, which will open up for the early rollout ahead of securing codes and formal cover.

Länk till analysen i sin helhet: https://www.redeye.se/research/854270/biovica-q1-2022-23-fda-approval?utm_source=finwire&utm_medium=RSS